van Houte Hans bought NRIX
July 30, 2025 · Form 4 insider transaction
van Houte Hans bought 2,886 shares of Nurix Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,886
Price
$0.00
Total value
N/A
Insidervan Houte Hans
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 30, 2025
Filing dateJuly 30, 2025
Shares owned after36,610
OwnershipDirect
10b5-1 planNo
AmendedNo